<DOC>
	<DOCNO>NCT01903161</DOCNO>
	<brief_summary>The purpose study evaluate delay myocardial protective effect RIPC patient undergo cardiac valve replacement surgery .</brief_summary>
	<brief_title>Effect Delayed Remote Ischemic Preconditioning Myocardial Injury</brief_title>
	<detailed_description>Ischemic precondition one strategy reduce perioperative myocardial injury . It concept briefly induce ischemia reperfusion myocardial injury reduce myocardial injury . But difficult apply ischemic precondition operative field , cross-clamping aorta coronary artery difficult invasive . Afterward concept remote ischemic preconditioning ( RIPC ) introduce ischemia remote organ like kidney , skeletal muscle reduce distant myocardial injury . It known myocardial protective effect ischemic preconditioning biphasic pattern . Early protective effect wane hour , recur 24-48 hour , persist 3-4 day . It call second window precondition delay ischemic preconditioning . Delayed ischemic preconditioning similar early ischemic preconditioning mechanism different produce protein mediate myocardial protection effect . Unlike ischemic preconditioning , little known delay effect RIPC . RIPC do apply compression cuff upper low extremity noninvasive easy deliver compare ischemic precondition do aorta coronary artery clamping . Delayed ischemic preconditioning perform one day surgery , safe easy apply RIPC clinical setting . And study investigator go evaluate cardioprotective effect delay RIPC . Myocardial injury predict elevation cardiac enzyme . Investigators go perform RIPC one day valve replacement surgery compare troponin I control group ass cardioprotective effect delay RIPC .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>18 80 year adult patient undergoing cardiac valve surgery Patient agree study Emergency operation Using inotropics , mechanical assist device Severe liver disease ( &gt; Child class II ) Severe renal disease ( Renal replacement therapy ) leave ventricular ejection fraction &lt; 30 % Cooperation major surgery ( Carotid endarterectomy ) Oral hypoglycemic agent ( Sulfonylurea , Glibenclamide ) peripheral vascular disease affect upper extremity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>delay remote ischemic preconditioning</keyword>
	<keyword>troponin</keyword>
	<keyword>valve replacement surgery</keyword>
</DOC>